币界网报道:Biotech stock surges 240% after breakthrough announcement, pulling broader sector indices up by 5.2%. The company revealed successful Phase 3 clinical trial results for its novel cancer treatment, triggering massive investor interest. Trading volume spiked to 250% above average as retail and institutional buyers rushed to acquire shares. Analysts note this marks the largest single-day biotech gain in three years, though some caution about potential volatility ahead of FDA approval decision expected next quarter. The rally lifted several peer stocks by 15-20%, creating a rare bright spot in an otherwise sluggish healthcare market this quarter.